Effects of a ganglionic blocking agent on the accumulation of DOPA in peripheral organs.
Andén
N E
NE
Department of Pharmacology, Karolinska Institutet, Stockholm, Sweden.
Grabowska-Andén
M
M
Schwieler
J
J
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology; D000818:Animals; D002714:Chlorisondamine / Q000494:pharmacology*; D004295:Dihydroxyphenylalanine / Q000378:metabolism*; D005730:Ganglionic Blockers / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010646:Phentolamine / Q000494:pharmacology; D014018:Tissue Distribution
D000317:Adrenergic alpha-Antagonists; D005730:Ganglionic Blockers; D004295:Dihydroxyphenylalanine; D002714:Chlorisondamine; D010646:Phentolamine